These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 20856869)
1. Role of CD45 signaling pathway in galactoxylomannan-induced T cell damage. Pericolini E; Gabrielli E; Bistoni G; Cenci E; Perito S; Chow SK; Riuzzi F; Donato R; Casadevall A; Vecchiarelli A PLoS One; 2010 Sep; 5(9):e12720. PubMed ID: 20856869 [TBL] [Abstract][Full Text] [Related]
2. Involvement of glycoreceptors in galactoxylomannan-induced T cell death. Pericolini E; Gabrielli E; Cenci E; De Jesus M; Bistoni F; Casadevall A; Vecchiarelli A J Immunol; 2009 May; 182(10):6003-10. PubMed ID: 19414751 [TBL] [Abstract][Full Text] [Related]
3. The microbial capsular polysaccharide galactoxylomannan inhibits IL-17A production in circulating T cells from rheumatoid arthritis patients. Pericolini E; Alunno A; Gabrielli E; Bartoloni E; Cenci E; Chow SK; Bistoni G; Casadevall A; Gerli R; Vecchiarelli A PLoS One; 2013; 8(1):e53336. PubMed ID: 23308194 [TBL] [Abstract][Full Text] [Related]
4. Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T-cells through activation of caspase-8. Pericolini E; Cenci E; Monari C; De Jesus M; Bistoni F; Casadevall A; Vecchiarelli A Cell Microbiol; 2006 Feb; 8(2):267-75. PubMed ID: 16441437 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis. Chow SK; Casadevall A Vaccine; 2011 Feb; 29(10):1891-8. PubMed ID: 21238568 [TBL] [Abstract][Full Text] [Related]
6. Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan. De Jesus M; Nicola AM; Rodrigues ML; Janbon G; Casadevall A Eukaryot Cell; 2009 Jan; 8(1):96-103. PubMed ID: 18952901 [TBL] [Abstract][Full Text] [Related]
7. CD45 down-regulates Lck-mediated CD44 signaling and modulates actin rearrangement in T cells. Wong NK; Lai JC; Birkenhead D; Shaw AS; Johnson P J Immunol; 2008 Nov; 181(10):7033-43. PubMed ID: 18981123 [TBL] [Abstract][Full Text] [Related]
9. Galactoxylomannan-mediated immunological paralysis results from specific B cell depletion in the context of widespread immune system damage. De Jesus M; Nicola AM; Frases S; Lee IR; Mieses S; Casadevall A J Immunol; 2009 Sep; 183(6):3885-94. PubMed ID: 19684080 [TBL] [Abstract][Full Text] [Related]
10. Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy. Vecchiarelli A; Pericolini E; Gabrielli E; Chow SK; Bistoni F; Cenci E; Casadevall A Immunotherapy; 2011 Aug; 3(8):997-1005. PubMed ID: 21843086 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of expression of the CD45 tyrosine protein phosphatase on the tyrosine phosphorylation of the lck, fyn, and c-src tyrosine protein kinases. Hurley TR; Hyman R; Sefton BM Mol Cell Biol; 1993 Mar; 13(3):1651-6. PubMed ID: 8441403 [TBL] [Abstract][Full Text] [Related]
12. Apoptosis mediated through CD45 is independent of its phosphatase activity and association with leukocyte phosphatase-associated phosphoprotein. Fortin M; Steff AM; Felberg J; Ding I; Schraven B; Johnson P; Hugo P J Immunol; 2002 Jun; 168(12):6084-9. PubMed ID: 12055218 [TBL] [Abstract][Full Text] [Related]
13. Tyrosine 192 within the SH2 domain of the Src-protein tyrosine kinase p56 Kästle M; Merten C; Hartig R; Kaehne T; Liaunardy-Jopeace A; Woessner NM; Schamel WW; James J; Minguet S; Simeoni L; Schraven B Cell Commun Signal; 2020 Nov; 18(1):183. PubMed ID: 33225946 [TBL] [Abstract][Full Text] [Related]
14. Expression of CD45 lacking the catalytic protein tyrosine phosphatase domain modulates Lck phosphorylation and T cell activation. Wang Y; Johnson P J Biol Chem; 2005 Apr; 280(14):14318-24. PubMed ID: 15687496 [TBL] [Abstract][Full Text] [Related]
15. Involvement of the capsular GalXM-induced IL-17 cytokine in the control of Cryptococcus neoformans infection. LaRocque-de-Freitas IF; Rocha JDB; Nunes MP; Oliveira PAV; Nascimento DO; Freire-de-Lima L; Takiya CM; Morrot A; Decote-Ricardo D; Previato JO; DosReis GA; Mendonça-Previato L; Freire-de-Lima CG Sci Rep; 2018 Nov; 8(1):16378. PubMed ID: 30401972 [TBL] [Abstract][Full Text] [Related]
16. The CD45 tyrosine phosphatase regulates CD3-induced signal transduction and T cell development in recombinase-deficient mice: restoration of pre-TCR function by active p56(lck). Pingel S; Baker M; Turner M; Holmes N; Alexander DR Eur J Immunol; 1999 Aug; 29(8):2376-84. PubMed ID: 10458749 [TBL] [Abstract][Full Text] [Related]
17. Changes in the role of the CD45 protein tyrosine phosphatase in regulating Lck tyrosine phosphorylation during thymic development. Falahati R; Leitenberg D J Immunol; 2007 Feb; 178(4):2056-64. PubMed ID: 17277109 [TBL] [Abstract][Full Text] [Related]
18. Engagement of CD45 alters early signaling events in human T cells co-stimulated through TCR + CD28. Bhatta A; Chan MA; Benedict SH Cell Immunol; 2020 Jul; 353():104130. PubMed ID: 32446033 [TBL] [Abstract][Full Text] [Related]
19. CD45-associated kinase activity requires lck but not T cell receptor expression in the Jurkat T cell line. Koretzky GA; Kohmetscher M; Ross S J Biol Chem; 1993 Apr; 268(12):8958-64. PubMed ID: 8473339 [TBL] [Abstract][Full Text] [Related]
20. CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling. Irles C; Symons A; Michel F; Bakker TR; van der Merwe PA; Acuto O Nat Immunol; 2003 Feb; 4(2):189-97. PubMed ID: 12496963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]